Labshake search
Citations for Leinco Technologies :
1 - 25 of 25 citations for IL 4 Mouse CHO since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) at a 40ng/ml concentration for 6 hours ...
-
bioRxiv - Immunology 2023Quote: ... allowed to sit for 3 hours and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) for 4 hr ...
-
bioRxiv - Neuroscience 2023Quote: ... and mouse IgG control (300ng/mouse, Leinco Technologies, I-536,) were dissolved in sterile PBS and administered intrathecally ...
-
bioRxiv - Cancer Biology 2020Quote: ... or with 100 μg/mouse anti-mouse-Pd-1 (Leinco Technologies, P372) one and six days post tumor injection ...
-
bioRxiv - Immunology 2021Quote: ... Mouse anti-mouse IFNAR1 (MAR1-5A3) and isotype control (GIR208, mouse anti-human IFNGR-α chain) were purchased from Leinco Technologies Inc ...
-
bioRxiv - Neuroscience 2023Quote: ... anti-mouse monoclonal IFNAR1 neutralizing antibody (MAR1, I-401; 300 ng/mouse,Leinco Technologies, I-401) and mouse IgG control (300ng/mouse ...
-
bioRxiv - Immunology 2022Quote: ... Co-cultures were treated with 10 µg/ml of anti-Mouse IFNα and anti-Mouse IFNβ (Leinco Technologies) every 24 hours ...
-
bioRxiv - Immunology 2022Quote: ... and 100 μg anti CTLA-4 (clone 9D9, Leinco Technologies) in volume of 200 μg 1X PBS.
-
bioRxiv - Immunology 2023Quote: ... 250µg of anti-mouse CD4 (Leinco Technologies, C1333) was administered by i.p ...
-
bioRxiv - Microbiology 2019Quote: ... or anti-mouse CD8a (Clone 53-6.7, Leinco Technologies, USA) or a combination of both was administered i.p ...
-
bioRxiv - Immunology 2022Quote: ... Mice were also treated with 4 μg mIFNβ neutralising antibodies (Leinco Technologies Inc). Control groups were treated with either buffer or an IgG isotype control antibody equivalently.
-
bioRxiv - Microbiology 2023Quote: ... Anti-mouse IFNAR-1 monoclonal antibody (clone MAR1-5A3) (Leinco Technologies) was used to transiently deplete Type I IFN during challenge as previously described [9].
-
bioRxiv - Microbiology 2019Quote: ... 0.5 mg of either anti-mouse CD4 (Clone GK1.5, Leinco Technologies, USA) or anti-mouse CD8a (Clone 53-6.7 ...
-
bioRxiv - Immunology 2023Quote: ... mouse IgG2a monoclonal antibody (IgG control) was purchased from Leinco Technologies (I-118). DX1 was purified as previously described (5) ...
-
bioRxiv - Cancer Biology 2023Quote: ... rat IgG2aκ anti-mouse PD1 antibody (Cat: P372, Clone: RMP1-14, Leinco Technologies) was injected intraperitoneally at a dose of 200μg/day ...
-
bioRxiv - Immunology 2024Quote: ... mice were intraperitoneally (i.p.) treated with neutralizing antibody against mouse CD8a (Leinco Technologies) or Rat IgG2a κ isotype control (100 μg/mouse ...
-
bioRxiv - Immunology 2020Quote: ... cells were incubated with an anti-IFNAR1 antibody or a mouse IgG1 isotype control (Leinco Technologies) for 20 minutes at 37°C ...
-
bioRxiv - Cancer Biology 2020Quote: ... Tumor bearing C57BL/6J mice were treated with either 100 μg/mouse isotype control antibody (Leinco Technologies, R1367) or with 100 μg/mouse anti-mouse-Pd-1 (Leinco Technologies ...
-
bioRxiv - Immunology 2020Quote: ... injected once with 1mg of anti-IFNAR1 (clone MAR1-5A3) or mouse IgG1 isotype control (clone HKSP) (Leinco Technologies) on either the day of inoculation (“early” ...
-
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsivenessbioRxiv - Immunology 2023Quote: ... checkpoint blockade was performed by intraperitoneal injection of 200 ug anti-mouse PD-L1 (clone 10F.9G2, Leinco Technologies) or isotype control anti-rat IgG2gb ...
-
bioRxiv - Microbiology 2023Quote: ... C57BL/6J mice were also administered anti-mouse IFNAR-1 monoclonal antibody (clone MAR1-5A3) (Leinco Technologies, Fenton, MO, USA) to transiently inhibit Type I IFN (IFN-α/β ...
-
bioRxiv - Immunology 2023Quote: ... they were treated with anti-PD-1 anti-CTLA-4 antibodies (clones RMP1-14 and 9H10, respectively, from Leinco Technologies Inc., Fenton, MO, USA): 200 µg ab/injection ...
-
bioRxiv - Microbiology 2021Quote: ... Male and female mice (4-5 weeks old) were treated by intraperitoneal injection with 2 mg of an anti-mouse IFNAR1 blocking antibody (MAR1-5A3, from Leinco Technologies). The next day ...
-
bioRxiv - Immunology 2021Quote: ... inoculum was replaced with CM1 containing 50 µM ACV and an anti-mouse IFNAR-1 antibody (Leinco Tech I-1188, 1:1000) for 5-6 days ...
-
bioRxiv - Immunology 2023Quote: ... Antibody levels specific to Delta variant RBD were assessed in mouse sera by direct ELISA: plates were coated with 1 μg/ml Delta variant RBD (#S951-100, Leinco Technologies, Inc.) or MT-001 diluted in PBS and incubated at 4°C overnight ...